Å·ÃÀAV

Introduction

Hyperspectral spectral imaging brings great advantages to pharmaceutical analysis by combining the best in spectroscopy and imaging. It solves many problems in analysing solid dosage forms: particle size, shape and distribution; moisture content and location, identification and quantification of individual constituents including polymorphic forms; content uniformity; and assessment of homogeneity. The data may be used in formulation development, understanding and monitoring manufacturing processes, ensuring continuous product quality, quality control and identifying counterfeit medicines. Imaging can involve many spectroscopies: near-infrared, Raman, X-ray and Terahertz as well as optical methods and mass spectroscopy. This symposium brings leading experts to give solutions to the big issues, top tips, best practice and current developments.

Useful links

Speakers

• Stephanie Brookes AZ, United Kingdom
• Gerard Byrne, Merck, United Kingdom
• Fiona Clarke, Pfizer, United Kingdom
• Sergei Kazarian, Imperial College London, United Kingdom
• Daniel Markl Graz University of Technology, Austria
• Johannes Khinast, Graz University of Technology, Austria
• Martin Kuentz University of Basel,, Switzerland
• Shen Qi, University of East Anglia, , United Kingdom

---

Venue

The Å·ÃÀAV

Science Room, The Å·ÃÀAV, Burlington House, Piccadilly, London, W1J 0BA, United Kingdom

Useful links

Organised by

Joint Pharmaceutical Analysis Group

Contact information

----
JPAG
Contact us by email

---